Sanofi India Ltd vs Zenotech Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 09, 2026

Key Highlights

The Latest Trading Price of Sanofi India Ltd is ₹ 3327 as of 08 May 15:30 . The P/E Ratio of Sanofi India Ltd is 30.8 as of December 2023 .The P/E Ratio of Zenotech Laboratories Ltd is 0 as of December 2023 . The Market Cap of Sanofi India Ltd is ₹ 18578 crore as of December 2023 .The Market Cap of Zenotech Laboratories Ltd is ₹ 0 crore as of December 2023 . The Revenue of Sanofi India Ltd is ₹ 578.9 crore as of Jun '24 .The Revenue of Zenotech Laboratories Ltd is ₹ 0 crore as of Jun '24 . The EBITDA of Sanofi India Ltd is ₹ 178.5 crore as of Jun '24 .The EBITDA of Zenotech Laboratories Ltd is ₹ 0 crore as of Jun '24 . The Net Profit of Sanofi India Ltd is ₹ 136.6 crore as of Jun '24 .The Net Profit of Zenotech Laboratories Ltd is ₹ 0 crore as of Jun '24 . The dividend payout of Sanofi India Ltd changed from 119.34 % to 0 % over 10 quarters. This represents a CAGR of -100.00% The dividend payout of Zenotech Laboratories Ltd changed from 0 % to 0 % over 10 quarters. This represents a CAGR of 0.0% .

About Sanofi India Ltd

Sanofi India Limited, was initially incorporated as 'Aventis Pharma Limited' in May, 1956.
The Company changed its name from Aventis Pharma Limited to Sanofi India Limited on May 11, 2012.
The Company is amongst the leading multinational companies (MNCs) in the Indian Pharmaceutical Market.
The Company is primarily engaged in the business of manufacturing and trading of drugs and pharmaceuticals.
It has its own manufacturing facility at Goa.

About Zenotech Laboratories Ltd

Zenotech Laboratories Limited was initially established as Sunline Technologies Limited in June, 1989 and changed to the present name w.e.f.
August 9, 2004.
Company is a loan licensing company catering exclusively to Sun Pharmaceutical Industries Limited, Promoter & holding company and they are specialized contract manufacturing services /processing in parenteral depot formulations, ophthalmic, oncology oral & injectables and general injectables.
Company's injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology. During financial year 2004-05, the Hon'ble High Court of Andhra Pradesh sanctioned the Scheme of Amalgamation with M/s.
Zenotech Technologies Limited with effect from November 1st , 2003.

FAQs for the comparison of Sanofi India Ltd and Zenotech Laboratories Ltd

Which company has a larger market capitalization, Sanofi India Ltd or Zenotech Laboratories Ltd?

Market cap of Sanofi India Ltd is 8,111 Cr while Market cap of Zenotech Laboratories Ltd is 287 Cr

What are the key factors driving the stock performance of Sanofi India Ltd and Zenotech Laboratories Ltd?

The stock performance of Sanofi India Ltd and Zenotech Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sanofi India Ltd and Zenotech Laboratories Ltd?

As of May 9, 2026, the Sanofi India Ltd stock price is INR ₹3522.25. On the other hand, Zenotech Laboratories Ltd stock price is INR ₹47.05.

How do dividend payouts of Sanofi India Ltd and Zenotech Laboratories Ltd compare?

To compare the dividend payouts of Sanofi India Ltd and Zenotech Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.